0001782656-23-000003.txt : 20230222 0001782656-23-000003.hdr.sgml : 20230222 20230222130559 ACCESSION NUMBER: 0001782656-23-000003 CONFORMED SUBMISSION TYPE: D PUBLIC DOCUMENT COUNT: 1 ITEM INFORMATION: 06b FILED AS OF DATE: 20230222 DATE AS OF CHANGE: 20230222 EFFECTIVENESS DATE: 20230222 FILER: COMPANY DATA: COMPANY CONFORMED NAME: REFRAME HEALTH, INC. CENTRAL INDEX KEY: 0001966671 IRS NUMBER: 872348633 STATE OF INCORPORATION: DE FISCAL YEAR END: 1231 FILING VALUES: FORM TYPE: D SEC ACT: 1933 Act SEC FILE NUMBER: 021-474015 FILM NUMBER: 23652076 BUSINESS ADDRESS: STREET 1: 447 SUTTER ST, STE 405 PMB 247 CITY: SAN FRANCISCO STATE: CA ZIP: 94108 BUSINESS PHONE: 980-785-3775 MAIL ADDRESS: STREET 1: 447 SUTTER ST, STE 405 PMB 247 CITY: SAN FRANCISCO STATE: CA ZIP: 94108 D 1 primary_doc.xml X0708 D LIVE 0001966671 REFRAME HEALTH, INC. c/o Reframe Health, Inc. 447 SUTTER ST, STE 405 PMB 247 SAN FRANCISCO CA CALIFORNIA 94108 980-785-3775 DELAWARE None None Corporation true 2021 Jessica Leigh Bell 447 Sutter St, Ste 405 PMB 247 San Francisco CA CALIFORNIA 94108 Executive Officer Director Cornelis Edward Johannes van der Wal c/o Reframe Health, Inc. 447 Sutter St, Ste 405 PMB 247 San Francisco CA CALIFORNIA 94108 Executive Officer Director Other Decline to Disclose 06b false 2023-02-09 false true true Sale and issuance of (i) Series Seed Preferred Stock; and (ii) Common Stock issuable upon conversion of Series Seed Preferred Stock. false 0 4803494 4803494 0 $2,803,500 of the Total Offering Amount and Total Amount Sold was converted from Simple Agreements for Future Equity. false 44 0 0 0 false REFRAME HEALTH, INC. /s/ Jessica Bell Jessica Bell Chief Executive Officer 2023-02-22